1. Wang, Zisong, Chen, Hongshan, Sun, Le, Tian, Sufang, Liu, Xiaoping. 2024. Uncovering the potential of APOD as a biomarker in gastric cancer: A retrospective and multi-center study. In Computational and structural biotechnology journal, 23, 1051-1064. doi:10.1016/j.csbj.2024.02.015. https://pubmed.ncbi.nlm.nih.gov/38455068/
2. Rassart, Eric, Desmarais, Frederik, Najyb, Ouafa, Bergeron, Karl-F, Mounier, Catherine. 2020. Apolipoprotein D. In Gene, 756, 144874. doi:10.1016/j.gene.2020.144874. https://pubmed.ncbi.nlm.nih.gov/32554047/
3. Xu, Wenbo, Gu, Shoubin, Zhang, Gang, Yan, Jinglong, Qin, Yong. 2023. APOD acts on fibroblast-like synoviocyte and chondrocyte to alleviate the process of osteoarthritis in vitro. In Journal of orthopaedic research : official publication of the Orthopaedic Research Society, 42, 296-305. doi:10.1002/jor.25690. https://pubmed.ncbi.nlm.nih.gov/37728985/
4. El-Darzi, Nicole, Mast, Natalia, Petrov, Alexey M, Bederman, Ilya, Pikuleva, Irina A. 2020. Studies of ApoD-/- and ApoD-/-ApoE-/- mice uncover the APOD significance for retinal metabolism, function, and status of chorioretinal blood vessels. In Cellular and molecular life sciences : CMLS, 78, 963-983. doi:10.1007/s00018-020-03546-3. https://pubmed.ncbi.nlm.nih.gov/32440710/
5. Yang, Hui-Hui, Wang, Xiaohong, Li, Siru, Akbar, Rubab, Fan, Guo-Chang. 2023. Lipocalin family proteins and their diverse roles in cardiovascular disease. In Pharmacology & therapeutics, 244, 108385. doi:10.1016/j.pharmthera.2023.108385. https://pubmed.ncbi.nlm.nih.gov/36966973/
6. Ran, Yamei, Wu, Kangqi, Hu, Chenglin, Peng, Yongmei, Sun, Wenjing. 2023. Downregulated APOD and FCGR2A correlates with immune infiltration and lipid-induced symptoms of irritable bowel syndrome. In Scientific reports, 13, 14211. doi:10.1038/s41598-023-41004-9. https://pubmed.ncbi.nlm.nih.gov/37648784/
智鼠故事 
